Monthly Communication Report

Corporation:	Hoffmann-La Roche Limited
Associated registration:	952745-64-66
Communication date:	2024-12-18
Posted date:	2025-01-14

Designated Public Office Holders who participated in the communication:	Tanya Ramsamy, Director, PDD Health Canada (HC) Martin McLean, Director, PDD Health Canada (HC)
List of Details Subject matter Detail Health Food and Drugs Act Modernization initiative as it relates to reform of drug submission review and approval process
Responsible Officer who filed this communication report:	BRIGITTE NOLET
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.